Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06534437
Title MEN1703 (SEL24) to Treat Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma (JASPIS-01) (JASPIS-01)
Acronym JASPIS-01
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ryvu Therapeutics SA
Indications
Therapies
Age Groups: senior | adult
Covered Countries POL

Facility Status City State Zip Country Details
Wojewódzki Szpital Specjalistyczny w Białej Podlaskiej Biała Podlaska Poland Details
Szpitale Pomorskie Sp. z o.o. Gdynia Poland Details
Narodowy Instytut Onkologii im. Marii Skłodowskiej Curie, Państwowy Instytut Badawczy Gliwice Poland Details
Pratia Hematologia Sp. z o.o. Katowice Poland Details
Pratia MCM Kraków Kraków Poland Details
Szpital Kliniczny Ministerstwa Spraw Wewnętrznych i Administracji z Warmińsko-Mazurskim Centrum Onkologii w Olsztynie Olsztyn Poland Details
Wojewódzki Szpital Zespolony im. L. Rydygiera w Toruniu Toruń Poland Details
Lux Med Onkologia Sp. z o.o. Warsaw Poland Details
Wojskowy Instytut Medyczny - Państwowy Instytut Badawczy Warsaw Poland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field